phosphorus
Dietary Supplementphosphorus supplement
NCT Number: NCT02329990
Phosphorus is a mineral that is naturally present in our foods and is required by our bodies for normal function. It has been found that phosphorus supplementation taken before meals has the potential to reduce meal size. However its long term effect has not been measured yet. It is well accepted that changes in body weight require about 3 months. Using body weight as the outcome, which is the ultimate outcome of weight loss approaches, would provide robust information on the role of phosphorus.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
A double-blind, randomised, placebo-controlled trial of 63 adults aged 18 to 45 years with a body mass index (BMI) of 25 kg/m2 or higher and normal kidney function at the American University of Beirut. Participants were randomly assigned to the placebo or phosphorus group where daily placebo or phosphorus supplements were ingested with three main meals (breakfast, lunch, and dinner) for a period of 12 weeks. Primary outcomes were changes in anthropometric measures, blood metabolites (including lipid profile, glucose, and insulin), and subjective appetite scores.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
phosphorus supplement
Time frame: 3 months
Time frame: 3 months
Time frame: 6 weeks
American University of Beirut Medical Center
Other
Premeal Phosphorus Supplementation for Reducing Energy Intake and Body Weight
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04567108
Body Weight, Pathological Conditions, Signs and Symptoms
Boston, Massachusetts, United States
View Trial DetailsNCT06169137
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT07079046
Appetite Regulation, Behavior
Valencia, Spain
View Trial DetailsNCT06195566
Body Weight, Diabetes Mellitus
Riga, Latvia
View Trial Details